Skip to main content

Drug That Treats Cocaine Addiction May Curb Colon Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 16, 2024.

By Dennis Thompson HealthDay Reporter

FRIDAY, Feb. 16, 2024 (HealthDay news) -- A drug first developed to treat cocaine addiction might also help slow the spread of advanced colon cancer, a new study suggests.

The drug vanoxerine appears to suppress cancer stem cell activity by essentially rewiring gene networks critical to tumor growth, the researchers explained.

“Tumors treated with vanoxerine become more susceptible to attack by the immune system due to the reactivation of ancient viral DNA fragments accumulated in our genome throughout evolution,” explained lead researcher Yannick Benoit, an associate professor of cellular and molecular medicine at the University of Ottowa in Canada.

“This finding is quite significant, considering that colorectal tumors tend to show poor response to standard immunotherapy,” Benoit added in a university news release.

Colon cancer is the world’s second-leading cause of cancer-related deaths, and it is considered a silent killer because it typically doesn’t show symptoms until the cancer is advanced.

Vanexorine interferes with a protein that transports dopamine, the brain chemical involved in sensations of pleasure and reward. Because of this, it was first developed to help people with an addiction to cocaine.

But the drug also suppresses a key enzyme in colon cancer cells, the researchers discovered.

Vanexorine suppressed stem cell activity in the tumors of colon cancer patients, as well as in tumors implanted into lab animals.

The drug also produced minimal toxic side effects in both humans and lab mice, Benoit said.

This indicates vanexorine could prove “a safe way to eliminate cancer stem cells in colorectal tumors without harming the ‘good stem cells’ in the body's organs,” Benoit added.

The findings were published Feb. 15 in the journal Nature Cancer.

Further research will be needed to fully test the ability of vanexorine to slow or stop colon cancer, the researchers added.

“For those unfortunate people diagnosed with advanced and aggressive forms of colorectal cancer, we profoundly hope our work can lead to the development of powerful options for treatment in the future and substantially increase their survival chances,” Benoit said.

Sources

  • University of Ottowa, news release, Feb. 13, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted February 2024

Read this next

Combo Therapy Boosts Survival for Advanced Colon Cancer

WEDNESDAY, May 29, 2024 -- People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds. A combination of two...

Colon Cancers Are Rising Among the Young: Know the Warning Signs

FRIDAY, May 24, 2024 -- Colon cancer is increasingly hitting Americans under the age of 50, and a new study outlines the warning signs that these young patients first...

FDA Panel Gives Nod to Blood Test for Colon Cancer

FRIDAY, May 24, 2024 -- A U.S. Food and Drug Administration advisory panel on Thursday recommended the approval of a new blood test that can spot colon cancer. The panel voted...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.